Companies
- Companies
- Company details
ABC International Pharma SRL
Out-licensing
A New Generation Xanthine Bronchodilator Devoid of Major Cardiovascular Adverse Effects: Doxofylline in Phase III Clinical Trials for the Treatment of COPD and Bronchial Asthma More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Nov 2011 - 6 pages - $75
Nov 2011 - 7 pages - $75
Nov 2011 - 6 pages - $75
Nov 2011 - 6 pages - $75
Nov 2011 - 5 pages - $75
Nov 2011 - 8 pages - $75
Nov 2011 - 6 pages - $75
Contact details
Giovanni Giraudi
Head office
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us